When Biomarker Blunders Cost Patients: A Decision Guide for Clinicians
Biomarkers are supposed to clarify, not confuse. Yet every month, I review charts where a slightly elevated troponin sent a patient to the cath lab un...
4 articles in this category
Biomarkers are supposed to clarify, not confuse. Yet every month, I review charts where a slightly elevated troponin sent a patient to the cath lab un...
Biomarkers should be the compass of precision medicine. But too often, they lead you straight into a swamp. You design the perfect experiment. Choose ...
Imagine running a large clinical trial for a new morphium-based drug. You measure a key biomarker in hundreds of patient. Half come back elevated—a po...
You just spent $200 on blood effort. The results come back — all green checkmarks, all within reference range. Your clinician smiles and says, 'everyt...